Exp Mol Med.
2017 Mar;49(3):e298. 10.1038/emm.2016.159.
Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson's disease
- Affiliations
-
- 1College of Pharmacy, Dongguk University, Goyang, Republic of Korea.
- 2Department of Neuroscience, Graduate School, Kyung Hee University, Seoul, Republic of Korea. bkjin@khu.ac.kr
- 3School of Life Sciences, BK21 plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea.
- 4Brain Science and Engineering Institute, Kyungpook National University, Daegu, Republic of Korea.
- 5Predictive model Research Center, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea. whshin@kitox.re.kr
- 6Department of Biochemistry and Signaling Disorder Research Center, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea. sywon@chungbuk.ac.kr
- 7Department of Biochemistry and Molecular Biology, Neurodegeneration Control Research Center, School of Medicine Kyung Hee University, Seoul, Republic of Korea.
- KMID: 2375785
- DOI: http://doi.org/10.1038/emm.2016.159
Abstract
- The effects of capsaicin (CAP), a transient receptor potential vanilloid subtype 1 (TRPV1) agonist, were determined on nigrostriatal dopamine (DA) neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease (PD). The results showed that TRPV1 activation by CAP rescued nigrostriatal DA neurons, enhanced striatal DA functions and improved behavioral recovery in MPTP-treated mice. CAP neuroprotection was associated with reduced expression of proinflammatory cytokines (tumor necrosis factor-α and interleukin-1β) and reactive oxygen species/reactive nitrogen species from activated microglia-derived NADPH oxidase, inducible nitric oxide synthase or reactive astrocyte-derived myeloidperoxidase. These beneficial effects of CAP were reversed by treatment with the TRPV1 antagonists capsazepine and iodo-resiniferatoxin, indicating TRPV1 involvement. This study demonstrates that TRPV1 activation by CAP protects nigrostriatal DA neurons via inhibition of glial activation-mediated oxidative stress and neuroinflammation in the MPTP mouse model of PD. These results suggest that CAP and its analogs may be beneficial therapeutic agents for the treatment of PD and other neurodegenerative disorders that are associated with neuroinflammation and glial activation-derived oxidative damage.
MeSH Terms
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine*
Animals
Capsaicin*
Cytokines
Dopamine*
Dopaminergic Neurons*
Mice
NADPH Oxidase
Necrosis
Neurodegenerative Diseases
Neurons
Neuroprotection
Nitric Oxide Synthase Type II
Nitrogen
Oxidative Stress*
Oxygen
Parkinson Disease*
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Capsaicin
Cytokines
Dopamine
NADPH Oxidase
Nitric Oxide Synthase Type II
Nitrogen
Oxygen
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease
- Effects of Nicotine on MPTP-induced Parkinson's Disease Animal Model
- Role of Oxidative Stress in Parkinson's Disease
- Differential Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on Motor Behavior and Dopamine Levels at Brain Regions in Three Different Mouse Strains
- 1alpha,25-Dihydroxyvitamin D3 Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation
